AWARDS & RECOGNITIONS
Untitled Page
Dr. Hans S. Keirstead recognized for his contributions to global health
California Stem Cell scientist and UC Irvine professor receives acknowledgment for his research in stem cell therapy
By Elaine MurphyPublished: November 14, 2011 11:55 AM
Dr. Hans S. Keirstead, Ph.D., of Irvine-based California Stem Cell (CSC), has been recognized in a genConnect article for his accomplishments in the global health field. Keirstead, who serves on CSC’s scientific advisory board and is an associate professor at UC Irvine, was among six innovative medical professionals recognized in an article by genConnect, which publishes content from experts in a variety of fields.
Among Keirstead’s accomplishments is a stem cell-based treatment for spinal cord injuries, developed at UC Irvine in 2004. The treatment uses stem cells to repair cells damaged by a spinal cord injury and allow patients to walk again. It was approved by the FDA in February, and will be the first stem cell treatment to be performed in human clinical trials in the U.S.
In June, Keirstead was invited to attend the Aspen Ideas Festival, a conference that gathers distinguished people to encourage intellectual exchange. The weeklong conference attracted speakers including Madeleine Albright, Bill Gates and Lance Armstrong. Keirstead was also the keynote speaker at the Translational Strategies for Tissue Engineering conference in Boston earlier this month, presenting on breakthroughs in cell-based treatments for incurable diseases, a speech that comes following CSC’s recent acquisition of a stem cell treatment program for metastatic melanoma.
Related headlines
California Stem Cell gains cancer therapy program
UCI stem cell researchers secure $9.35 million in grants
Ambry Genetics expands through new partnership
Readers Feedback:
i like your article
Comment at 11/14/2011
|
||||
|
Among Keirstead’s accomplishments is a stem cell-based treatment for spinal cord injuries, developed at UC Irvine in 2004. The treatment uses stem cells to repair cells damaged by a spinal cord injury and allow patients to walk again. It was approved by the FDA in February, and will be the first stem cell treatment to be performed in human clinical trials in the U.S. In June, Keirstead was invited to attend the Aspen Ideas Festival, a conference that gathers distinguished people to encourage intellectual exchange. The weeklong conference attracted speakers including Madeleine Albright, Bill Gates and Lance Armstrong. Keirstead was also the keynote speaker at the Translational Strategies for Tissue Engineering conference in Boston earlier this month, presenting on breakthroughs in cell-based treatments for incurable diseases, a speech that comes following CSC’s recent acquisition of a stem cell treatment program for metastatic melanoma. Related headlines California Stem Cell gains cancer therapy program UCI stem cell researchers secure $9.35 million in grants Ambry Genetics expands through new partnership |
||||
Readers Feedback:
i like your article
| Comment at 11/14/2011 |
